Delivery Order SPE2DB22D2206-SPE2DB24FKL19
Award Date
9/19/24
Potential Completion Date
9/20/24
Potential Value
$24K
Federal Agency
Defense Logistics Agency
Awardee
Amerisourcebergen Drug Corp
Ultimate Awardee
Not listed
NAICS Category
424210 - Drugs and Druggists' Sundries Merchant Wholesalers
PSC Category
6505 - Drugs And Biologicals
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award, with the ID SPE2DB22D1202|SPE2DB24FVNL1, was made by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp's Corporate Office division. The $15,567.27 firm fixed price delivery order is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product. The contract has an ultimate completion date of September 13, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded multiple indefinite delivery contracts (IDCs) by...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corporation, a major pharmaceutical distributor, to supply Actemra Actpen 162 mg/0.9 ml drug vials. The $15,530.73 Firm Fixed Price delivery order contract has an ultimate completion date of August 29, 2024. Amerisourcebergen, through its Corporate Office division, provides a wide range of pharmaceutical and medical supplies to various government agencies and healthcare programs, including...
This federal contract award, with ID SPE2DB22D2206|SPE2DB24FJA26, was issued by the Defense Logistics Agency (DLA) to the prime contractor Amerisourcebergen Drug Corp, Corporate Office Division. The $8,920.44 firm fixed-price delivery order is for the pharmaceutical product Actemra Actpen 162 mg/0.9 ml, with a completion date of July 3, 2024. Amerisourcebergen is a major supplier of pharmaceutical products and medical supplies to the U.S. government, particularly the Department of Defense...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $20,419.76 firm fixed-price delivery order is for ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty pharmaceutical product. The contract has an ultimate completion date of March 20, 2025. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award to Amerisourcebergen Drug Corp's Corporate Office Division is for the delivery of the pharmaceutical product Actemra Actpen, a medication used to treat certain autoimmune and inflammatory conditions. The fixed-price delivery order, valued at $2,328.36, was issued by the Defense Logistics Agency (DLA) and has a completion date of June 18, 2024. Amerisourcebergen, a major pharmaceutical distribution company, holds a significant Indefinite Delivery Contract (IDC) with...
This federal contract award to Amerisourcebergen Drug Corp, Corporate Office Division, was issued by the Defense Logistics Agency (DLA) for the delivery of ACTEMRA ACTPEN 162 MG/0.9 ML pharmaceutical product. The $25,041.82 Firm Fixed Price delivery order contract has an ultimate completion date of August 20, 2024. Amerisourcebergen, a major pharmaceutical distributor, has been awarded numerous federal contracts and Indefinite Delivery Contracts (IDCs) by the DLA and other agencies to supply a...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $14,843.19 firm fixed price delivery order contract covers the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty medication. The contract has an ultimate completion date of March 18, 2025. AmerisourceBergen holds a $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $33,397.75 Firm Fixed Price Delivery Order is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a pharmaceutical product, to support military healthcare programs. The contract has an ultimate completion date of November 5, 2024 and is not designated as a set-aside. AmerisourceBergen holds a $999,999,999...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor. The $6,384.37 firm-fixed-price delivery order is for the supply of ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty injectable medication. The award has an ultimate completion date of October 11, 2024 and does not have a set-aside designation. Amerisourcebergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $28,259.22 firm fixed-price delivery order is for ACTEMRA ACTPEN 162 MG/0.9 ML 0.9ML, a specialty pharmaceutical product. The contract has an ultimate completion date of April 2, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...